- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT06002763
Ocena systemu informacji o wynikach zgłaszanych przez pacjentki (PROMIS)-29 v2.1 dla kobiet po porodzie
There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women.
This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surveys at defined time points (0, 2, 6, and 12 weeks after delivery). The investigators will subject survey data to statistical measures of validity and reliability comparing with contemporaneously collected surveys of established metrics for quality of life (WHOQoLBREF) and general (global) state of health (numerical rating score 1-100).
The hypothesis is that the PROMIS-29 v2.1 questionnaire is a statistically valid and reliable means of assessing physical and mental health in a postpartum population.
Przegląd badań
Status
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Ontario
-
Toronto, Ontario, Kanada, M5G1X5
- Mount Sinai Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Patients who deliver vaginally or by scheduled cesarean section at Mount Sinai Hospital.
Opis
Inclusion Criteria:
- 18 years old and over
- singleton births
- 37 or more weeks gestational age
- multiparous or nulliparous patients
- spontaneous vaginal delivery or scheduled cesarean delivery with labor analgesia or neuraxial anesthesia
- give informed written consent
Exclusion Criteria:
- refusal to take part
- are unable to give or have withdrawn consent
- patients unable to communicate fluently in English
- patients who are less than 18 years old
- patients who had fetal demise or severely morbid fetal conditions such as intubation, cooling, expected surgical correction of congenital anomaly during hospitalization (although NICU admissions will be included)
- patients who were admitted in ICU
- patients who had failed neuraxial analgesia such as replaced epidurals or failed spinal requiring conversion to general anesthesia
- patients who had general anesthesia for cesarean delivery as defined by "GETA", including sedatives and deep sedation if not intubated
- patients who had intrapartum cesarean or had assisted/operative (i.e. vacuum, forceps) vaginal delivery.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: COHORT
- Perspektywy czasowe: PROSPECTIVE
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
Vaginal delivery
Patients who have vaginal deliveries with neuraxial labour analgesia. |
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Inne nazwy:
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Inne nazwy:
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Inne nazwy:
|
|
Cesarean delivery
Patients who have a scheduled cesarean delivery with neuraxial anesthesia. |
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Inne nazwy:
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Inne nazwy:
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Ramy czasowe: 24 hours
|
The PROMIS survey score at 24 hours postpartum |
24 hours
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Ramy czasowe: 24 hours
|
The WHOQoLBREF survey score at 24 hours postpartum |
24 hours
|
|
EQ-5D-3L1 (not an acronym) survey score
Ramy czasowe: 24 hours
|
The EQ-5D-3L1 survey score at 24 hours postpartum |
24 hours
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Ramy czasowe: 2 weeks
|
The PROMIS survey score at 2 weeks postpartum |
2 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Ramy czasowe: 2 weeks
|
The WHOQoLBREF survey score at 2 weeks postpartum |
2 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Ramy czasowe: 2 weeks
|
The EQ-5D-3L1 survey score at 2 weeks postpartum |
2 weeks
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Ramy czasowe: 6 weeks
|
The PROMIS survey scores at 6 weeks postpartum |
6 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Ramy czasowe: 6 weeks
|
The WHOQoLBREF survey score at 6 weeks postpartum |
6 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Ramy czasowe: 6 weeks
|
The EQ-5D-3L1 survey score at 6 weeks postpartum |
6 weeks
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Ramy czasowe: 12 weeks
|
The PROMIS survey score at 12 weeks postpartum |
12 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Ramy czasowe: 12 weeks
|
The WHOQoLBREF survey score at 12 weeks postpartum |
12 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Ramy czasowe: 12 weeks
|
The EQ-5D-3L1 survey score at 12 weeks postpartum |
12 weeks
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Ronald George, MD, MOUNT SINAI HOSPITAL
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 23-03
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .